ORIGINAL ARTICLE
SDCBP-AS1 destabilizes β-catenin by regulating ubiquitination and SUMOylation of hnRNP K to suppress gastric tumorigenicity and metastasis
Jing Han, Menglin Nie, Cong Chen, Xiaojing Cheng, Ting Guo, Longtao Huangfu, Xiaomei Li, Hong Du, Xiaofang Xing, Jiafu Ji
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/9/2022 doi:10.1002/cac2.12367
REVIEW
Current updates of CRISPR/Cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
Khaled S. Allemailem, Mohammed A Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Fahd Khaleefah Alkhaleefah, Arshad Husain Rahmani, Amjad Ali Khan
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/9/2022 doi:10.1002/cac2.12366
ORIGINAL ARTICLE
N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA
Xiao Zheng, Qi Wang, You Zhou, Dachuan Zhang, Yiting Geng, Wenwei Hu, Changping Wu, Yufang Shi, Jingting Jiang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/8/2022 doi:10.1002/cac2.12363
ORIGINAL ARTICLE
Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma
Miao Li, Xi Zhang, Mimi Wang, Yaohui Wang, Jiali Qian, Xiaoxia Xing, Zhiming Wang, Yang You, Kun Guo, Jie Chen, Dongmei Gao, Yan Zhao, Lan Zhang, Rongxin Chen, Jiefeng Cui, Zhenggang Ren
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 10/1/2022 doi:10.1002/cac2.12364
LETTER TO THE EDITOR
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
Nicolas Alejandro Fraunhoffer, Analía Meilerman Abuelafia, Brice Chanez, Martin Bigonnet, Odile Gayet, Julie Roques, Eduardo Chuluyan, Nelson Dusetti, Juan Iovanna
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/30/2022 doi:10.1002/cac2.12365
LETTER TO THE EDITOR
A novel histone deacetylase inhibitor exerts promising anti-breast cancer activity via triggering AIFM1-dependent programmed necrosis
Peipei Shan, Feifei Yang, Jie Yu, Lirong Wang, Yuhua Qu, Huiran Qiu, Hua Zhang, Sujie Zhu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/25/2022 doi:10.1002/cac2.12362
REVIEW
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment
Elena Verdugo, Iker Puerto, Miguel ángel Medina
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/21/2022 doi:10.1002/cac2.12361
REVIEW
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Xinpeng Yin, Ruiyuan Xu, Jianlu Song, Rexiati Ruze, Yuan Chen, Chengcheng Wang, Qiang Xu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/15/2022 doi:10.1002/cac2.12360
REVIEW
Non-small cell lung cancer in China
Peixin Chen, Yunhuan Liu, Yaokai Wen, Caicun Zhou
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/8/2022 doi:10.1002/cac2.12359
REVIEW
Breast cancer: an up-to-date review and future perspectives
Ruoxi Hong, Binghe Xu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/8/2022 doi:10.1002/cac2.12358
